These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18028031)

  • 41. The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism.
    Krämer SD; Testa B
    Chem Biodivers; 2008 Dec; 5(12):2465-578. PubMed ID: 19089818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver.
    van de Bovenkamp M; Groothuis GM; Meijer DK; Olinga P
    Toxicol In Vitro; 2008 Apr; 22(3):771-8. PubMed ID: 18207697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy.
    Obach RS
    Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug metabolism and pharmacokinetics.
    Benedetti MS; Whomsley R; Poggesi I; Cawello W; Mathy FX; Delporte ML; Papeleu P; Watelet JB
    Drug Metab Rev; 2009; 41(3):344-90. PubMed ID: 19601718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.
    de Graaf IA; Olinga P; de Jager MH; Merema MT; de Kanter R; van de Kerkhof EG; Groothuis GM
    Nat Protoc; 2010 Sep; 5(9):1540-51. PubMed ID: 20725069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Theoretical prediction of safety and efficacy of drugs--safety].
    Sato T; Kariya K
    Nihon Yakurigaku Zasshi; 1996 Sep; 108(3):183-5. PubMed ID: 9091458
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of water deprivation on drug pharmacokinetics: correlation between drug metabolism and hepatic CYP isozymes.
    Lee JH; Oh JM; Lee MG
    Arch Pharm Res; 2008 Aug; 31(8):951-64. PubMed ID: 18787780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug metabolism and pharmacokinetics in drug discovery.
    Roberts SA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [How to identify and prevent pharmacokinetically relevant drug-drug interactions].
    Ritter CA
    Med Monatsschr Pharm; 2009 Oct; 32(10):364-74; quiz 375-6. PubMed ID: 19886226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of precision-cut liver slices as an in vitro tool for evaluating liver function.
    Gandolfi AJ; Wijeweera J; Brendel K
    Toxicol Pathol; 1996; 24(1):58-61. PubMed ID: 8839281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of circadian rhythms on the kinetics of drugs in humans.
    Baraldo M
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Past, present, and future applications of precision-cut liver slices for in vitro xenobiotic metabolism.
    Ekins S
    Drug Metab Rev; 1996 Nov; 28(4):591-623. PubMed ID: 8959392
    [No Abstract]   [Full Text] [Related]  

  • 55. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
    Filimonova AA; Ziganshin AU; Ziganshina LE
    Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional integrity of precision-cut liver slices from deer and cattle.
    Sivapathasundaram S; Howells LC; Sauer MJ; Ioannides C
    J Vet Pharmacol Ther; 2004 Apr; 27(2):79-84. PubMed ID: 15096104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
    Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The development of drug metabolism research as expressed in the publications of ASPET: Part 2, 1959-1983.
    Murphy PJ
    Drug Metab Dispos; 2008 Jun; 36(6):981-5. PubMed ID: 18322071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues.
    de Kanter R; Monshouwer M; Meijer DK; Groothuis GM
    Curr Drug Metab; 2002 Feb; 3(1):39-59. PubMed ID: 11878310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.